Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome
Publication
, Conference
De Beur, SJ; Miller, PD; Weber, TJ; Peacock, M; Insogna, KL; Kumar, R; Rauch, F; Luca, D; Theodore-Oklota, C; Lampl, K; Martin, JS; Carpenter, TO
Published in: JOURNAL OF BONE AND MINERAL RESEARCH
November 1, 2018
Duke Scholars
Published In
JOURNAL OF BONE AND MINERAL RESEARCH
EISSN
1523-4681
ISSN
0884-0431
Publication Date
November 1, 2018
Volume
33
Start / End Page
50 / 50
Location
Montreal, CANADA
Publisher
WILEY
Conference Name
Annual Meeting of the American-Society-for-Bone-and-Mineral-Research
Related Subject Headings
- Anatomy & Morphology
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences
- 09 Engineering
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
De Beur, S. J., Miller, P. D., Weber, T. J., Peacock, M., Insogna, K. L., Kumar, R., … Carpenter, T. O. (2018). Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome. In JOURNAL OF BONE AND MINERAL RESEARCH (Vol. 33, pp. 50–50). Montreal, CANADA: WILEY.
De Beur, Suzanne Jan, Paul D. Miller, Thomas J. Weber, Munro Peacock, Karl L. Insogna, Rajiv Kumar, Frank Rauch, et al. “Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome.” In JOURNAL OF BONE AND MINERAL RESEARCH, 33:50–50. WILEY, 2018.
De Beur SJ, Miller PD, Weber TJ, Peacock M, Insogna KL, Kumar R, et al. Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome. In: JOURNAL OF BONE AND MINERAL RESEARCH. WILEY; 2018. p. 50–50.
De Beur, Suzanne Jan, et al. “Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome.” JOURNAL OF BONE AND MINERAL RESEARCH, vol. 33, WILEY, 2018, pp. 50–50.
De Beur SJ, Miller PD, Weber TJ, Peacock M, Insogna KL, Kumar R, Rauch F, Luca D, Theodore-Oklota C, Lampl K, Martin JS, Carpenter TO. Burosumab Improved Serum Phosphorus, Osteomalacia, Mobility, and Fatigue in the 48-Week, Phase 2 Study in Adults with Tumor-induced Osteomalacia Syndrome. JOURNAL OF BONE AND MINERAL RESEARCH. WILEY; 2018. p. 50–50.
Published In
JOURNAL OF BONE AND MINERAL RESEARCH
EISSN
1523-4681
ISSN
0884-0431
Publication Date
November 1, 2018
Volume
33
Start / End Page
50 / 50
Location
Montreal, CANADA
Publisher
WILEY
Conference Name
Annual Meeting of the American-Society-for-Bone-and-Mineral-Research
Related Subject Headings
- Anatomy & Morphology
- 32 Biomedical and clinical sciences
- 31 Biological sciences
- 11 Medical and Health Sciences
- 09 Engineering
- 06 Biological Sciences